Association of MBL2, TGF-β1 and CD14 gene polymorphisms with lung disease severity in cystic fibrosis;Associação entre os polimorfismos dos genes MBL2, TGF-β1 e CD14 com a gravidade da doença pulmonar na fibrose cística

Jornal Brasileiro de Pneumologia

Volumn 35, Issue 4, 2009, Pages 334-342

  Faria, Elisangela Jacinto de ^a   Faria, Isabel Cristina Jacinto de ^a   Ribeiro, José Dirceu ^a   Ribeiro, Antônio Fernando ^a   Hessel, Gabriel ^a   Bertuzzo, Carmen Sílvia ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Cystic fibrosis; Genetic; Mannose binding lectin; Polymorphism; Severity of illness index; Transforming growth factor beta

Indexed keywords

EID: 67649540913     PISSN: 18063713     EISSN: 18063713     Source Type: Journal    
DOI: 10.1590/s1806-37132009000400007     Document Type: Article

References (27)

1. Davies JC, Griesenbach U, Alton E. Modifier genes in cystic fibrosis. Pediatr Pulmonol. 2005;39(5):383-91.
2. Rommens JM, Iannuzzi MC, Kerem B, Drumm ML, Melmer G, Dean M, et al. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science. 1989;245(4922):1059-65.
3. Cystic fibrosis mutation database [homepage on the Internet]. [updated 2007 Mar 02; cited 2008 Jul 1]. Available from: http://www.genet.sickkids.on.ca/cftr/
4. Knowles MR. Gene modifiers of lung disease. Curr Opin Pulm Med. 2006;12(6):416-21.
5. Drumm ML, Konstan MW, Schluchter MD, Handler A, Pace R, Zou F, et al. Genetic modifiers of lung disease in cystic fibrosis. N Engl J Med. 2005;353(14):1443-53.
6. Vanscoy LL, Blackman SM, Collaco JM, Bowers A, Lai T, Naughton K, et al. Heritability of lung disease severity in cystic fibrosis. Am J Respir Crit Care Med. 2007;175(10):1036-43.
7. Slieker MG, Sanders EA, Rijkers GT, Ruven HJ, van der Ent CK. Disease modifying genes in cystic fibrosis. J Cyst Fibros. 2005;4 Suppl 2:7-13.
8. Boyle MP. Strategies for identifying modifier genes in cystic fibrosis. Proc Am Thorac Soc. 2007;4(1):52-7.
9. Guardia A, Lozano F. Mannose-binding lectin deficiencies in infectious and inflammatory disorders. Rev Med Microbiol. 2003;14:41-52.
10. Grande JP. Role of transforming growth factor-beta in tissue injury and repair. Proc Soc Exp Biol Med. 1997;214(1):27-40.
11. Martin AC, Laing IA, Zhang G, Brennan S, Winfield K, Sly PD, et al. CD14 C-159T and early infection with Pseudomonas aeruginosa in children with cystic fibrosis. Respir Res. 2005;6:63.
12. Gibson LE, Cooke RE. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics. 1959;23(3):545-9.
13. Santos CIS, Ribeiro JD, Ribeiro AF, Hessel G. Critical analysis of scoring systems used in the assessment of Cystic Fibrosis severity: State of the art. J Bras Pneumol. 2004;30(3):286-98.
14. Woodhead JL, Fallon R, Figuered H, Longdale J, Malcom AD. Alternative methodology of gene diagnosis. In: Davies KE, editor. Human genetic diseases-a practical approach. Oxford: IRL Press Limited; 1986. p. 51-64.
15. Steffensen R, Thiel S, Varming K, Jersild C, Jensenius JC. Detection of structural gene mutations and promoter polymorphisms in the mannan-binding lectin (MBL) gene by polymerase chain reaction with sequence-specific primers. J Immunol Methods. 2000;241(1-2):33-42.
16. Perrey C, Turner SJ, Pravica V, Howell WM, Hutchinson IV. ARMS-PCR methodologies to determine IL-10, TNF-alpha, TNF-beta and TGF-beta 1 gene polymorphisms. Transpl Immunol. 1999;7(2):127-8.
17. Koppelman GH, Reijmerink NE, Colin Stine O, Howard TD, Whittaker PA, Meyers DA, et al. Association of a promoter polymorphism of the CD14 gene and atopy. Am J Respir Crit Care Med. 2001;163(4):965-9.
18. Mahadeva R, Lomas DA. Secondary genetic factors in cystic fibrosis lung disease. Thorax. 2000;55(6):446.
19. Muhlebach MS, MacDonald SL, Button B, Hubbard JJ, Turner ML, Boucher RC, et al. Association between mannan-binding lectin and impaired lung function in cystic fibrosis may be age-dependent. Clin Exp Immunol. 2006;145(2):302-7.
20. Gabolde M, Guilloud-Bataille M, Feingold J, Besmond C. Association of variant alleles of mannose binding lectin with severity of pulmonary disease in cystic fibrosis: cohort study. BMJ. 1999;319(7218):1166-7.
21. Davies JC, Turner MW, Klein N; London MBL CF Study Group. Impaired pulmonary status in cystic fibrosis adults with two mutated MBL-2 alleles. Eur Respir J. 2004;24(5):798-804.
22. Garred P, Pressler T, Madsen HO, Frederiksen B, Svejgaard A, Høiby N, et al. Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J Clin Invest. 1999;104(4):431-7.
23. Yarden J, Radojkovic D, De Boeck K, Macek M Jr, Zemkova D, Vavrova V, et al. Polymorphisms in the mannose binding lectin gene affect the cystic fibrosis pulmonary phenotype. J Med Genet. 2004;41(8):629-33.
24. Dorfman R, Sandford A, Taylor C, Huang B, Frangolias D, Wang Y, et al. Complex two-gene modulation of lung disease severity in children with cystic fibrosis. J Clin Invest. 2008;118(3):1040-9.
25. Arkwright PD, Laurie S, Super M, Pravica V, Schwarz MJ, Webb AK, et al. TGF-beta(1) genotype and accelerated decline in lung function of patients with cystic fibrosis. Thorax. 2000;55(6):459-62.
26. Wojnarowski C, Frischer T, Hofbauer E, Grabner C, Mosgoeller W, Eichler I, et al. Cytokine expression in bronchial biopsies of cystic fibrosis patients with and without acute exacerbation. Eur Respir J. 1999;14(5):1136-44.
27. Brazova J, Sismova K, Vavrova V, Bartosova J, Macek M Jr, Lauschman H, et al. Polymorphisms of TGF-beta1 in cystic fibrosis patients. Clin Immunol. 2006;121(3):350-7.